Anadolu Medical Center
| Turkey | Thailand | South Korea | |
| Radiation therapy for colorectal cancer | from AUD $7,200 | ≈ AUD $10,800 | ≈ AUD $13,000 |
| Colectomy (large bowel resection) | from AUD $7,200 | ≈ AUD $13,700 | from AUD $19,400 |
| Chemotherapy for breast cancer | from AUD $4,300 | ≈ AUD $7,200 | from AUD $4,300 |
Professor Bulent Karagoz is a leading medical oncologist at Anadolu Medical Center, specialising in tumour biology and immunotherapy for complex gastrointestinal cancers.
Dr. Banu Atalar is a professor and radiation oncologist at Anadolu Medical Center. She is an Honorary Fellow of the American College of Radiology (H.FACR). She completed a clinical research fellowship in stereotactic radiosurgery at Stanford University. Stereotactic radiosurgery and MR-guided adaptive SRS make up 75% of her clinical practice.
Dr. Huseyin Baloglu is a pathologist at Anadolu Medical Center in Turkey. He leads liquid biopsy and precision oncology services. Dr. Baloglu holds a patent for molecular diagnostics in thyroid cancer treatment. He completed training at Albert Einstein College of Medicine and Heidelberg University.
Dr. Ayshe Okumush is a radiation oncologist at Private NeoLife Medical Center. She earned her MD from Karadeniz Technical University in 2003. She completed a residency in radiation oncology at Sisli Etfal Training and Research Hospital from 2006 to 2011.
She served as a specialist at Diyarbakir Uckuyular Training and Research Hospital from 2011 to 2013 and at Sisli Etfal from 2013 to 2016. She then worked at Yeni Yuzyil University Private Gaziosmanpasa Hospital from 2016 to 2026. She joined NeoLife in 2026.
Memberships: Turkish Society for Radiation Oncology (TROD) and the European Society for Radiotherapy and Oncology (ESTRO). Clinical focus: SRS, SRT, SBRT; VMAT, IMRT; radiotherapy for head and neck, lung, and brain tumors; SGRT, TBI, and 3D brachytherapy.
Follow-up care coordination involves getting a translated medical file from Turkish specialists for an Australian GP. JCI-accredited centres like Anadolu Medical Center provide English documentation covering pathology, surgical margins, and TNM staging. Australian oncologists then use these records to manage Medicare-funded surveillance. This includes CEA blood tests and CT imaging.
Bookimed Expert Insight: Turkish oncology packages frequently bundle initial post-operative checks, but long-term surveillance transitions to Australia. Packages at Hisar Hospital Intercontinental include 6-night recovery stays, while Anadolu Medical Center offers 15-day stays for complex resections. This extra time allows for the finalisation of pathology reports. It means Australian doctors receive exact staging data for local Medicare-supported follow-ups.
Patient Consensus: Patients in Turkey emphasise obtaining a written surveillance plan. This plan should specify the exact timing for CT scans and CEA blood tests. Consensus suggests confirming whether a GP, oncologist, or colorectal surgeon in Australia will lead the five-year monitoring phase.